---
title: "SINOTHERAPEUTICS: The Sitagliptin Metformin Extended-Release Tablets have received approval from the U.S. FDA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261833244.md"
description: "SINOTHERAPEUTICS announced that its generic drug application for Sitagliptin Metformin Extended-Release Tablets has received temporary approval from the U.S. FDA. The drug was developed by MERCK SHARPDOHME and is used to improve blood sugar control in adults with type 2 diabetes"
datetime: "2025-10-20T08:21:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261833244.md)
  - [en](https://longbridge.com/en/news/261833244.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261833244.md)
---

# SINOTHERAPEUTICS: The Sitagliptin Metformin Extended-Release Tablets have received approval from the U.S. FDA

According to the Zhitong Finance APP, SINOTHERAPEUTICS (688247.SH) announced that the company received a notification from the U.S. Food and Drug Administration (“FDA”) stating that the abbreviated new drug application (referred to as “ANDA”, i.e., U.S. generic drug application) for Sitagliptin Metformin Extended-Release Tablets submitted to the U.S. FDA has been temporarily approved. Sitagliptin Metformin Extended-Release Tablets were developed by MERCK SHARPDOHME and were approved for marketing in the U.S. in February 2012, intended for improving blood sugar control in adults with type 2 diabetes

### Related Stocks

- [688247.CN](https://longbridge.com/en/quote/688247.CN.md)

## Related News & Research

- [JD Vance Says Hunter Biden Is 'Welcome' To Seek Payout From DOJ's $1.8 Billion 'Slush Funds'—'The President...Has Pardoned..'](https://longbridge.com/en/news/287054505.md)
- [Here's how Kevin O'Leary and Big Tech can solve the AI data center backlash](https://longbridge.com/en/news/286808041.md)
- [Former Spanish Prime Minister Zapatero is under investigation linked to airline bailout](https://longbridge.com/en/news/287039440.md)
- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [Assessing BlueNord (OB:BNOR) Valuation After Its US$400 Million Refinancing Deal](https://longbridge.com/en/news/287098111.md)